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The principles underlying fair and equitable sharing of benefits derived from the utilization of 
genetic resources are set out in Article 15 of the UN Convention on Biological Diversity, 
which stipulate that access to genetic resources is subject to the prior informed consent of the 
country where such resources are located and to mutually agreed terms regarding the sharing 
of benefits that could be derived from such access. One issue of particular concern for pro-
vider countries is how to monitor and track genetic resources once they have left the provider 
country and enter into use in a variety of forms. This report was commissioned to provide a 
detailed review of advances in DNA sequencing technologies, as those methods apply to 
identification of genetic resources, and the use of globally unique persistent identifiers for 
persistently linking to data and other forms of digital documentation that is linked to individ-
ual genetic resources. While the report was written for an audience with a mixture of tech-
nical, legal, and policy backgrounds it is relevant to the genomics community as it is an ex-
ample of downstream application of genomics information. 
 
Background 
There is a natural tendency for practitioners with-
in any given field to focus intently inward on sub-
jects of common interest, and to communicate, of-
tentimes to the exclusion of all others about those 
things that are of common interest.  In fields that 
are rapidly evolving, such as genomics, this makes 
it difficult for those outside the community to ap-
preciate the ramifications that current develop-
ments might have on discussions on larger issues.  
Likewise, those engaged in topics that are peri-
pheral may be equally unaware of how new tech-
nologies may affect the interpretation and social 
policies, regulations, or laws at the national, re-
gional, or international level.  Recently, we were 
invited to contribute our shared views on such a 
topic, as co-authors of a white paper for the Secre-
tariat of the UN Convention on Biological Diversity 
(CBD) [1,2]. The CBD was adopted in 1992 and en-
tered into force in 1993.  At present, there are 192 
Parties (nations) to the convention.  
 The three principal  objectives of the CBD are:  
conservation of biological resources,  sustainable 
use of its components, and fair and equitable shar-
ing of benefits arising out of their utilization. The 
principles underlying fair and equitable sharing of 
benefits deriving from  the utilization of genetic   Garrity et al. 
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resources are set out in Article 15 of the CBD, 
which stipulates that access to genetic resources is 
subject to the prior informed consent of the coun-
try where such resources are located and to mu-
tually agreed terms regarding the sharing of bene-
fits that could be derived from such access. 
Further to a call for action by the World Summit 
on Sustainable Development in 2002, the Confe-
rence of the Parties to the CBD mandated a subsid-
iary body to negotiate an international regime on 
access and benefit-sharing in order to further en-
able  Article 15 and other relevant provisions of 
the CBD [3,4]. At COP 9, in May 2008, it was 
agreed that negotiation of the international re-
gime should be completed by COP 10 in October 
2010. 
One issue raised during the negotiation process, 
which is of particular concern for provider coun-
tries, is the monitoring and tracking of genetic re-
sources; that is to say what happens to those re-
sources once they have left the provider country 
and enter into use in a variety of forms. Previous-
ly, the issue of monitoring and tracking had been 
considered in discussions about an internationally 
recognized certificate of origin/source/legal 
provenance.  An expert group was established by 
COP to further examine this potential tool or in-
strument that could assist to track or trace genetic 
resources.   
At COP 9, in relation to the issue of monitoring and 
tracking, the Parties requested that two studies be 
carried out to inform the negotiation process (de-
cision IX/12., paragraph 13): 
Recent developments in methods to 
identify genetic resources directly 
based on DNA sequences; 
To identify the different possible ways 
of tracking and monitoring genetic 
resources through the use of per-
sistent global unique identifiers, 
including the practicality, feasibili-
ty, costs and benefits of the differ-
ent options; 
Against this background, we were commissioned 
to provide a detailed report that could inform 
the negotiation process on these issues.   The 
studies we prepared were aimed at the negotia-
tors of the international regime, and are written 
for an audience with a mixture of technical, legal, 
and policy backgrounds. However, the topics we 
discuss are also relevant to the genomics com-
munity and we welcome any comments the 
readers of SIGS might like to share.   
Introduction 
Technological innovations, in areas such as DNA 
sequencing  and information technology are cha-
racterized by exponential development rates and 
lead to results that are typically unanticipated 
when first introduced.  Three examples demon-
strate this clearly. In 1995 it took Fleischmann et 
al. thirteen months to sequence the complete ge-
nome of Haemophilus influenzae at a cost of ap-
proximately fifty cents per base pair [5]. Today a 
bacterial genome can be sequenced in less than a 
day for pennies per base pair and the possibility of 
sequencing a complete bacterial genome in a few 
hours for under $1000 looms in the near future 
[6]. In 1983 TCP/IP, the underlying protocol of the 
Internet  became operational [7].  As of June 30, 
2008, 1.463 billion people use the Internet accord-
ing to Internet World Stats with the greatest 
growth in usage between 2000-2008 occurring in 
Africa (1,031.2 %), Latin America/Caribbean 
(669.3 %) and Asia (406.1 %)[8]. On August 6, 
1991, the European Organization for Nuclear Re-
search (CERN) publicly announced the new World 
Wide Web project [9]. Eighteen years later the In-
dexed Web contains at least 25.9 billion pages) 
[10]. According to UN statistics, 64% of all mobile 
phone users can now be found in the developing 
world. With a compound annual  growth rate of 
49.3% over the last seven years, Africa has become 
a key market for global telecom operators; and it is 
expected that this market will continue to grow 
faster than any other region over the next three to 
five years [11,12]. In parts of Africa, health teams 
are synchronizing their mobile devices and collect-
ing data from rural clinics to provide better health 
care  [13]. Clearly the digital divide that once ex-
isted is closing rapidly and databases and other dig-
ital resources are accessible today to anyone, any-
where, with an internet connection and a browser 
on a computer, a handheld device, or even a cell 
phone.  
It is in this environment of rapid technological 
innovations and global information access in 
which the CBD must work to ensure the sustain-
able use of biodiversity as a means to justify and 
underwrite its preservation. As part of this effort 
an international regime (IR) on accessing genetic 
resources and sharing benefits derived from 
their utilization is currently being negotiated by 
the  Conference of Parties of the CBD [3]. The Monitoring and Tracking Genetic Resources 
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purpose of this paper is to assist the COP in the-
senegotiations by providing a detailed examina-
tion of the following technical issues:  
Recent developments in methods to 
identify genetic resources directly 
based on DNA sequences;  
Identification of different possible 
ways of tracking and monitoring 
genetic resources through the use 
of persistent global unique iden-
tifiers (GUIDs), including the prac-
ticality, feasibility, costs and bene-
fits of the different options. 
This paper presents the overall summary from a 
more extensive Access and Benefit Sharing report 
made for the United Nations. 
Genetic resources 
Genetic resources are used worldwide by many 
different industries, academic institutions, and 
environmental organizations to achieve various 
goals, ranging from developing new commercial 
products and processes to exploring new re-
search avenues for cataloging and preserving bio-
tic specimens arising from biodiversity invento-
ries. In Article 2 of the CBD, genetic resources are 
defined as “genetic material of actual or potential 
value” and are further defined as “any material of 
plant, animal, microbial or other origin containing 
functional units of heredity.” The value of these 
resources need not be exclusively genetic materi-
al. It may also be derived information, such as 
functional or regulatory pathways, structural po-
lymers or biological functions of an organism that 
are encoded for by the genetic material, including 
metabolic products that have some practical ap-
plications (e.g., low molecular weight organic ac-
ids; anti-microbial agents, such as antibiotics, and 
other biopharmaceuticals, flavors and fragrances, 
enzymes for industrial applications). 
Provenance, tracking and terms of use 
Currently, the use of, and access to, specified ge-
netic resources are governed by contractual 
agreements between the providers and users of 
those resources. For the purpose of this study it is 
assumed that such agreements are in compliance 
with all the relevant existing legal and other in-
struments at national, regional, and international 
levels relating to ABS. Contractual negotiations 
that follow the voluntary Bonn Guidelines result in 
a set of accompanying documents that explicitly 
detail the terms of any agreement including prior 
informed  consent (PIC) and material transfer 
agreements (MTAs) and possibly Mutually Agreed 
Terms (MATs) and Certificates of Origin (CoO). 
Such documents by themselves do not provide a 
means by which a specified genetic resource(s) 
can be singled out and tracked, but do establish an 
important part of the baseline information that 
must be collected and made accessible to various 
parties to the agreement. These agreements also 
establish the conditions for access to both the re-
sources and information over time and should al-
so specify what types of information are required 
to follow along with any genetic resource and any 
real or abstract derived products, either for fixed 
periods of time or in perpetuity. With this minimal 
information in hand, it becomes possible to devise 
reasonable and extensible models to track each 
genetic resource as it moves from its point of ori-
gin through one or more user organizations for a 
variety of purposes.  
It should be understood that a large-scale tracking 
system that meets the needs of the IR does not yet 
exist. Smaller-scale implementations do, however; 
and have features that are desirable in the antic-
ipated tracking system for genetic resources. 
These are discussed in detail in part II of the ex-
tended published report [2]. We have drawn from 
prior experience with those smaller scale systems 
to gain useful insights into the requirements of a 
robust, reliable, and trustworthy tracking system 
that could accommodate the needs of a diverse 
end-user community working in pure and applied 
research, international trade, regulation, and en-
forcement. It is important to stress that develop-
ment of a complete tracking system for genetic re-
sources must consider non-technical issues as 
well, including realistic policies that address com-
plex social, business, and scientific requirements. 
This will ensure widespread acceptance and 
usage. It is not uncommon for technically sound 
information systems to fail because user needs 
were not met or the system rigidly modeled prac-
tices that became obsolete because of changes in 
technologies external to the system, but critical to 
the organizational goals, that were not anticipated 
or could not be incorporated into the system. This 
is particularly true in the life sciences and is dis-
cussed in part III of the extended report [2].   
Redefining genetic resources  
Whereas whole organisms or parts of organisms 
were once the subject of study and trade, contem-  Garrity et al. 
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porary biology has expanded its focus to incorpo-
rate molecular and informatics methods (in silico). 
These newer methods allow us to describe living 
systems not only on the basis of readily observa-
ble traits, but also upon their genetic potential 
based on a direct analysis of selected portions of 
the genome or the entire genome. As a result, ge-
netic resources are now being  used in various 
forms ranging from extracted DNA (including 
from mixed populations in metagenomic studies) 
to various types of sequence data that are stored 
in public and private databases. These derived ge-
netic resources are readily copied, mobile,  and 
readily accessible to a global audience and can be 
used for a variety of purposes (e.g., expression in 
heterologous hosts, engineered chimeric path-
ways, synthetic life forms) that may have not been 
intended or anticipated in original agreements.  
Therefore, it can be argued that rights and obliga-
tions under the IR may extend to the exploitation 
of genetic resources, regardless of how those re-
sources are constituted. Although a discussion of 
the merits of such thinking is beyond the scope of 
our charge, we believe it prudent to consider the 
consequences. Under such an interpretation, a 
system for tracking genetic resources would have 
to provide a means for providers to track the uses 
of the data and information derived from their ge-
netic resources. The task of  tracking successive 
uses of such information, although complex, is 
theoretically feasible and would require the craft-
ing of appropriate metadata,  careful utilization 
and implementation of a persistent identifier sys-
tem, and development of custom tracking applica-
tions (See [14]  for an example). However, it 
should also be understood that such a system 
would have to accurately reflect our current and 
future knowledge of biology. The vast majority of 
gene sequences is ubiquitous in nature and often-
times occurs in distribution patterns that do not 
necessarily conform to national boundaries. It 
should also be understood that current technology 
allows the rapid synthesis and evolution of genes 
and pathways in vitro and in silico. Therefore, ap-
parent misuse of a resource by a user or third par-
ty may not be actual misuse. Rather, it may be an 
instance of coincidental use of a like resource ob-
tained independently. It is with these points in 
mind, that we offer the Secretariat and the COP 
our observations and recommendations on the 
agreed upon topics. 
Single gene identification methods 
The rapid development of molecular technologies 
that enables characterization of organisms at a 
genetic level has opened  new  possibilities  in 
species identification. In 1977 Woese and Fox  
produced the first phylogenetic classification of 
prokaryotes1
Woese's work revealed that bacteria and archaea 
formed two deep and very distinct evolutionary 
lineages. The third lineage, based on this model of 
evolution, encompasses the eukaryotes (the plants 
and animals), which characteristically posses a 
membrane enclosed nucleus and organalles 
(including the mitochondria and chloroplasts). 
Eukaryotes possess ribosomes, which in turn 
contain an 18S rRNA. The eukaryotic 18S rRNA 
gene shares many homologous regions with the 
prokaryotic 16S rRNA gene.  Thus, it is possible to 
make meaningful comparisons of all species based 
on the sequence of this gene. Since the sequence of 
the 16S rRNA gene is approximately 1540 
nucleotides in length, there is sufficent 
information content to allow for very far reaching 
comparisons.  
  based on the comparison of the 
nucleotide sequence of the 16S rRNA gene [15]. 
This gene is universally distributed, highly 
conserved, evolves very slowly, and plays a key 
structural role in the ribosome, which in turn is 
part of the cellular machinery involved in protein 
synthesis. All life forms, as we know them, possess 
ribosomes, so according to the early proposals of 
Pauling and Zukerkandel, the sequence of this 
molecule could serve as a molecular chronometer, 
by which the evolution of different species could 
be traced [16]. 
Woese's discovery has led to a radically different 
understanding of the evolutionary history of all 
life, which is generally well accepted and has led 
to the abandonment  of alternative models of 
classification (e.g., Whittaker's five kingdoms). 
16S rRNA Sequence analysis has become the 
principal method by which bacteria and archeae 
are now classified. In the past two decades, 
thousands of new taxa have been described based 
on this method, along with numerous taxonomic 
rearrangements. Concurrent improvements in 
sequenceing methodologies have greatly accel-
erated this process. Today, 16S rRNA sequence 
data is routinely used to presumptively identify 
                                                 
1 The term prokaryote is a contentious but commonly used 
name to group bacteria and archaea together based on their 
absence of a nucleus; a feature found in all eukaryotes Monitoring and Tracking Genetic Resources 
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bacteria and archaea to the genus level and to 
deduce community composition in environmental 
surveys and in metagenomic analyses.  These 
efforts are well supported by publicly available 
tools and highly curated data sets of aligned 16S 
rRNA  [17-19].  
But it is now well understood that a single gene 
may not be adequate to yield an accurate 
identification to the species or subspecies level 
and additional gene sequences along with other 
data may be required. Confounding issues include 
non-uniform distribution of sequence dissim-
ilarity among different taxa and instances in which 
multiple copies of the 16S rRNA gene may be 
present in the same organism that differ by more 
that 5% sequence dissimilarity. This can lead to 
different presumptive identifications for the same 
individual, depending on which 16S rRNA gene is 
analyzed.  We also understand that numerous 
instances of misidentification and taxonomic 
synonomies have accumulated prior to the 
widespread adoption of these methods and that 
discrepancies between names and correct 
classification remain to be resolve. In such 
instances, molecular evidence needs to be used to 
support taxonomic revision rather than 
attempting to force-fit earlier concepts into a 
classification based on reproducible molecular 
and genomic evidence.  
These observations are relevant to the 
development of a tracking system for genetic 
resources because taxonomic names are 
commonly used in the scientific, technical,  and 
medical literature as well as in numerous laws and 
regulations governing commerce, agriculture, 
public safety,  and public health. But taxonomic 
names are not suitable for use as as they are not 
unique, not persistent, and do not exist in a one-
to-one relationship with the abstract or concrete 
objects they identify.  
Analogous developments are currently underway 
in the fields of botany and zoology. Sequence 
based methods have been applied on a limited 
basis to various species of eukaryotes for many 
years. However, it was not until recently that the 
community began to accept the possibility that a 
single gene could be used for identification of 
eukaryotes. This approach is now being applied in 
a highly coordinated fashion to build useful 
resources to identify plants, animals, fungi, 
protists,  and other distinct eukaryotic lineages. 
Consensus is beginning to  emerge on a small 
number of preferred target genes, of which a 
partial sequence of the mitochondrial cytochrome 
c oxidase subunit I gene is preferred. This highly 
coordinated effort is much more recent than the 
corresponding activities in microbiology, and 
championed by the Consortium for the BarCode of 
Life (CBoL) program [20]. 
Implications of genome sequencing  
In part III of the extended report, we provide an 
in-depth review of next generation sequencing 
(NGS) technologies [2]. Because of the rapid pace 
at which these technologies are evolving this sec-
tion should be viewed as a set of “snapshots” of 
the current state of the art, and a harbinger of the 
future of DNA based identification methods. We 
discuss methods that are currently in use; those 
that have just recently become available on the 
market, (near-future NGS methods); and those 
that are still under development. These NGS se-
quencing technologies enable the rapid evaluation 
of specific regions of the genome of a biological 
entity  to  determine to which genus, species, or 
strain  it  belongs  (e.g.,  the  16S  rRNA gene  for 
taxonomic purposes for bacteria; the use of 
cytochrome  c  oxidase subunit I (cox1)  for 
eukaryotes). 
Fueled by innovations in high-throughput DNA 
sequencing, high-performance computing,  and 
bioinformatics, the rate of genomic discovery has 
grown exponentially. To date, there are more than 
500 complete genome sequences and more than 
4000 ongoing genome and metagenome sequenc-
ing projects covering species ranging from bacte-
ria to yeast to higher eukaryotes. The results that 
stream forth from these studies are constantly re-
fining and reshaping our understanding of biolog-
ical systems. As part of the funding requirement of 
various governmental and non-governmental 
agencies, the vast majority of these sequences are 
made publicly available from the INSDC databases 
after brief embargo periods during which time the 
funding recipients may publish their results [21]. 
Typically, after one year, the sequence data is 
open to anyone wanting to publish their own find-
ings or mine those data for other purposes. 
All indications are that future genome-based tech-
nologies will be “smaller, cheaper, faster”. This 
will make genome-enabled detection tools availa-
ble to a wide audience in both developed and de-
veloping nations. Clearly, very low cost sequenc-
ing technology along with sophisticated bioinfor-  Garrity et al. 
http://standardsingenomics.org    83 
matics tools will soon be available to presumptive-
ly identify a genetic resource, with a high degree 
of accuracy and reliability, at the point of need.  
Tracking genetic resources 
The concept of identification is central to the goals 
of the CBD ABS regime, which rests on the funda-
mental principle that a user is legally obliged to 
share in the benefits obtained through the use of a 
particular genetic resource with the provider. 
Identification is one of the first steps in tracking 
an  item over time. Under some circumstances, 
identification to the family, genus, or species level 
may be adequate and identification methods 
based on a single gene may be appropriate (e.g., 
biotic inventories, wild-life management, ecologi-
cal studies). However, there is ample evidence 
based on over half a century of natural product 
screening and supporting genomic data that such 
approaches may be inadequate if the trait of inter-
est occurs in subpopulations within a species or is 
widely distributed across taxonomic boundaries 
as a result of horizontal gene exchange.  A useful 
tracking system must accurately reflect current 
knowledge and readily incorporate new know-
ledge via continuous feedback over a long time 
frame as transactions involving genetic resources 
may be long lived (>20 yrs).  
The number of items to be identified and tracked 
within the anticipated system is a challenge and 
the extent of the task will depend largely on the 
legally required “granularity” of the identification. 
Although there is a tendency to view this as a tax-
onomic problem and the anticipated tracking sys-
tem as a taxonomic resource, it is decidedly dis-
tinct. What is required is a mechanism to track the 
fate of multiple genetic resources as each is trans-
ferred from one party to another and various ab-
stract and concrete products are generated along 
the way. In some cases the product may be useful 
for taxonomic purposes and in other cases tax-
onomic information may be useful for predictive 
purposes, but in most cases taxonomic informa-
tion would be ancillary. Systems of such design 
are challenging as they are open-ended and must 
work with data of varying granularity. The point is 
not to define all the types of data a priori, but to 
define lightweight metadata models that define 
genetic resources and allow them to be perma-
nently bound other to varying amounts and types 
of information that accumulate about that genetic 
resource over time. Inherent in such designs are 
links established through aggregates of foreign 
keys that may exist within a single system or on a 
remote systems accessible via the internet. 
Persistent identifiers 
In their simplest form, persistent identifiers are 
nothing more than unique labels that are assigned 
to objects in a one-to-one relationship. Such iden-
tifiers are well understood in computing systems 
and we present examples of identifiers as used in 
a large-scale laboratory information management 
system  (LIMS) in Part II of the extended report 
[2]. When used in the context of the internet, the 
concept of persistent identification is frequently 
coupled with the concept of actionability, implying 
that the PID is persistently linked to a specific ob-
ject and when actuated, will always return the 
same response to the end-user (typically a hyper-
link to a specific web page or other form of digital 
content). In this context PIDs differ from URLs, 
which are used to create hyperlinks and provide 
the internet address of where a given object is 
stored. As the storage location is not persistent, 
some "behind-the-scenes" mapping of object iden-
tifiers to object locations is required (resolution). 
This topic is covered in more detail in part IV of 
the extended report [2]. 
Persistent identifiers are a powerful enabling 
technology that provides a way to efficiently cope 
with chronic problems such as broken links and 
the general difficulty of reliable and reproducible 
information retrieval on the Internet. For example, 
PIDs associated with published articles allow rap-
id and accurate tracking of written works.  PIDs 
are also in use within the life sciences such as the 
INSDC identifiers (e.g., sequence accession num-
bers used at GenBank, EMBL, and DNA Database 
of Japan) [22-24]. However, these are largely insti-
tution specific, i.e., used only within the institu-
tions for which they were created, or are con-
trolled by those organizations, such as the 
PubMed ID, issued by the National Library of Med-
icine.  
Six PID schemes currently used across different 
domains and by a number of different organiza-
tions are reviewed and include: Uniform Resource 
Name (URN: [25]);  Persistent Uniform Resource 
Locator (PURL: [14]); Archival Resource Key (ARK 
[26]); Life Science Identifiers (LSID [27]); Handle 
System (Handle [28]); Digital Object Identifier 
System (DOI [29]). This review also addresses the 
questions that need to be answered when an or-
ganization is assessing the need to incorporate a 
PID scheme into its data management plan.  Monitoring and Tracking Genetic Resources 
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Each of these identifiers is used in well-defined 
settings in which the data and metadata models of 
the underlying repositories were established a 
priori. The identifiers serve as a means of directly 
accessing a specific record or other form of digital 
content or the associated metadata. If the identifi-
er is actionable, then it is possible to retrieve the 
linked object using the familiar interface of a web-
browser. However, with the use of web services 
that provide structured access to the content of in-
terest automatically (e.g. from a database or appli-
cation on a handheld device using embedded 
PIDs), similar results can be achieved where an in-
teractive interface is not suitable. 
An effective and durable PID scheme requires on-
going maintenance and therefore ongoing re-
sources. While some tasks can be automated, re-
sponsibility for this ongoing task must be assigned 
to an agency, program, or office, or to a trusted 
third-party who can guarantee reliability and vir-
tually constant up-time to meet the needs of vari-
ous end-user communities. In the case of integrat-
ing a persistent identifier scheme within the ABS 
process, the use of a trusted third party with the 
appropriate expertise and resources is  probably 
the best option, especially if that third party is al-
ready engaged in such activity for other purposes. 
The selection of an appropriate PID for the CBD 
ABS and related activities will be critical for its 
broad utility and community acceptance. Howev-
er, it does not obviate the importance of carefully 
defining precisely what the identifiers refer  to, 
and what will be returned by queries of various 
types. It is possible to develop a range of PID ser-
vices that could, for instance, provide a direct link 
to digital and paper copies of entire documents, 
such as PICs, MTAs, CoOs,  and other relevant 
agreements  or  permit tracking of genetic re-
sources or parts of genetic resources in a future 
proof method, or do so on-the-fly. It could also be 
possible to track the transfer of materials and the 
corresponding agreements to third parties in a 
manner that is consistent with the rights and obli-
gations of all parties to the initial agreement or to 
subsequent agreements. Similarly, the ability to 
track these genetic resources into the STM, gener-
al interest and patent literature is technically feas-
ible.  
Services such as these could be facilitated through 
the use of a trusted third party acting as a clearing-
house for registering ABS-related events (e.g., PIC, 
MTAs, CoO, and other relevant agreements)  ac-
cording to a set of well-understood business rules. 
With  such  a clearinghouse  in place, it becomes 
possible to traverse a series of transactions back-
ward and forward in time, even in instances 
where some ambiguity may exist. By drawing on 
highly interconnected information, it is possible to 
follow events, and  to accurately recreate those 
events, when adequate documentation is availa-
ble. Such a system would be useful for monitoring 
the use of genetic resources, especially since there 
will be instances in which long periods of time 
may exist between the time PICs, MTAs, and CoO 
are executed and some commercial or non-
commercial product results. With the selection of 
the appropriate PID system, a system of this de-
sign could support human and machine queries 
and facilitate the retrieval of all relevant docu-
ments from public and private databases, includ-
ing the STM literature, patent, and regulatory da-
tabases. This is discussed in more depth in part IV 
(CBD/ABS services) [2]. 
Conclusion and Recommendations 
Reduction to practice will require a commitment 
of interested parties from different sectors (e.g., 
government, industries, botanical gardens, mu-
seums, academia, etc) to define standards for the 
key documents that are instrumental to imple-
menting the ABS. Business rules and policies also 
need to be established in concrete terms so that 
useful prototypes can be built and assumptions 
(technical, legal, and social) tested and refined.  In 
part V of the extended report we offer the Secreta-
riat and COP five broad recommendations along 
with our reasoning [2]. In summary, these are: 
a) Promptly establish the minimum in-
formation that must be contained 
in all relevant documents that are 
required for compliance with the 
IR (PIC, MTA, MAT, CoO). Stipulate 
which documents are mandatory 
and which are optional. 
b) Adopt a well-developed and widely 
used Persistent Identifier PID sys-
tem (e.g. DOI) that leverages an ex-
isting infrastructure and derives 
support from multiple sources ra-
ther than developing a new system 
or adopting one that is untested in 
commercial applications.  
c)  Carefully consider the current and 
future needs of genetic  resource   Garrity et al. 
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providers and users as the concept 
of resource tracking is deliberated. 
Biological and functional diversity 
of genetic resources are decidedly 
distinct. The system, including its 
human resource component, must 
be able to accommodate both with 
priority given to the latter as func-
tional diversity is what leads to 
practical utility. 
d)  Deploy light-weight applications 
that use browser technology for in-
teractive use and publish well do-
cumented application program in-
terfaces to support other web ser-
vice. Develop strong policies go-
verning access and use of the re-
source to avoid data abuse. 
e)  Deploy one or several prototype 
tracking systems to validate under-
lying concepts and refine critical 
elements that will be needed in a 
fully operational system. During 
the developmental phase address 
erroneous preconceptions and fo-
cus on making the system as 
transparent as possible. 
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